A former employee of syringe maker Unilife Corp., who claimed he was the subject of a retaliatory firing for pointing out in 2011 that the company was in violation of FDA regulations, has withdrawn and apologized for his claims.
In 2013, Talbot Todd Smith filed his whistleblower action against Unilife in the U.S. District Court for the Eastern District of Pennsylvania. Smith alleged Unilife falsely led shareholders to believe through press releases that, in accordance with U.S. Food and Drug Administration manufacturing or “validation” standards, it had the ability to manufacture the Unifill syringe to specifications for commercial distribution.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
